APA (7th ed.) Citation

B, H., W, L., J, D., H, L., T, Z., S, Y., . . . F, C. (2021). 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. Vaccines, 9(12), . https://doi.org/10.3390/vaccines9121407

Chicago Style (17th ed.) Citation

B, Han, et al. "12 Months Persistent Immunogenicity After Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial." Vaccines 9, no. 12 (2021). https://doi.org/10.3390/vaccines9121407.

MLA (9th ed.) Citation

B, Han, et al. "12 Months Persistent Immunogenicity After Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial." Vaccines, vol. 9, no. 12, 2021, https://doi.org/10.3390/vaccines9121407.